Virpax Pharmaceuticals (VRPX) Financial Statements

Virpax Pharmaceuticals's market cap is currently $26.09K. The company's EPS TTM is $-128.83; its P/E ratio is ―; Virpax Pharmaceuticals is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-5.25. See an overview of income statement, balance sheet, and cash flow financials.